A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease (AGY-010)

NCT03707730 PHASE2 COMPLETED

To assess the efficacy and safety of AGY vs placebo when administered to individuals age 10 to 65 years with medically proven CD and on a gluten free diet

Details

Lead sponsor	Igy Inc.
Phase	PHASE2
Status	COMPLETED
Enrolment	161
Start date	Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Dec 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Celiac Disease

Interventions

• AGY
• placebo

Countries

Canada